Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07WTH
|
||||
| Former ID |
DIB003710
|
||||
| Drug Name |
UltraCD40L
|
||||
| Synonyms |
SP-D-CD40L; 4-trimer SP-D-CD40L (anticancer, adjuvant), Multimeric Biotherapeutics
|
||||
| Indication | Systemic lupus erythematosus [ICD9: 710; ICD10:M32] | Phase 1 | [544212] | ||
| Company |
Biogen Idec
|
||||
| Target and Pathway | |||||
| Target(s) | Tumor necrosis factor ligand superfamily member 5 | Target Info | Modulator | [544292] | |
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| NF-kappa B signaling pathway | |||||
| Cell adhesion molecules (CAMs) | |||||
| T cell receptor signaling pathway | |||||
| Intestinal immune network for IgA production | |||||
| Malaria | |||||
| Toxoplasmosis | |||||
| Asthma | |||||
| Autoimmune thyroid disease | |||||
| Systemic lupus erythematosus | |||||
| Allograft rejection | |||||
| Primary immunodeficiency | |||||
| Viral myocarditis | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.